Interestingly, glioma cell treatment with TNF-α enhances SERT-dependent serotonin uptake and also seems to activate the MAPK signaling pathway, whereas pre-treatment with the MAPK inhibitor SB203580 attenuates the TNF-α-mediated stimulation of serotonin transport [89]. Here, SLC6A4 is linked to glioma.